Published in Hepatitis Weekly, May 1st, 1995
At issue are intermittent malfunctions in an instrument that performs the screening assay for Hepatitis B surface antigen (HBsAg) over this two-year period.
At this time, Red Cross officials believe the risk for infectious disease transmission to be extremely remote for several reasons:
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.